Friday, September 18, 2015 | 8:30 AM - 4:30 PM
Speakers: George S. Bloom (University of Virginia), Peter Davies (Feinstein Institute for Medical Research), Marc I. Diamond (University of Texas, Southwestern Medical Center), Michael Hutton (Eli Lilly and Company), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Hartmuth C. Kolb (Johnson & Johnson, Janssen R&D), Nicole Leclerc (Université de Montréal), Richard Ransohoff (Biogen)
Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.
Tuesday, September 29, 2015 | 12:00 PM - 5:00 PM
Speakers: Samie R. Jaffrey (Weill Cornell Medical College), Amy E. Palmer (University of Colorado)
This symposium features state of the art chemical tools and imaging strategies for metal ions, redox signaling species, and metabolites in the cell, cellular delivery and targeting approaches, and their application to studying life processes.
Friday, October 16, 2015 | 8:30 AM - 5:00 PM
Keynote Speakers: Sonia Angell (New York City Department of Health and Mental Hygiene), Rogan Kersh (Wake Forest University)
Speakers: Eliza Barclay (NPR's Salt), Sanjay Basu (Stanford University), Julia Belluz (VOX), Jason P. Block (Harvard Medical School), Juan Rivera Dommarco (Research Center in Nutrition and Health, National Institutes of Public Health, Mexico), Helena Bottemiller Evich (Politico), Matthew Harding (Duke University), Terry Huang (CUNY School of Public Health), Nancy Huehnergarth (Nancy F. Huehnergarth Consulting), Barbara A. Laraia (Berkeley School of Public Health), Jeff Niederdeppe (Cornell University)
Well-informed nutrition policy decisions which consider scientific evidence should strive for effective policies that improve health outcomes on a large scale. This one-day conference will focus on emerging research methodology, how to interpret research outcomes and how these can be used to inform policy.
October 18 - 22, 2015
Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatkowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute), Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Stefano Rivella (Children's Hospital of Philadelphia), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital), Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)
Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.
Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM
Speakers: Andras Bauer (Boehringer Ingelheim), Alex Huang (Genentech), Michael Jackson (Sanford-Burnham Medical Research Institute), Bryan Laffitte (Genomics Institute of the Novartis Research Foundation), Jonathan Lee (Eli Lilly), Lorenz Mayr (AstraZeneca), Friedrich Metzger (Hoffmann-La Roche), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), John Tallarico (Novartis Institutes for Biomedical Research), Robert Temple (US Food and Drug Administration)
This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.
Tuesday, July 28, 2015 | 8:30 AM - 6:00 PM
Speakers: Marc D Chioda (Pfizer Inc), Leonard James (Pfizer Inc), Iya Khalil (GNS Healthcare), Michael Matheny (Vanderbilt University), Jason H. Moore (University of Pennsylvania), Nicholas Tatonetti (Columbia University Medical Center), Craig P. Webb (NuMedii, Inc), Chunhua Weng (Columbia University), Diane Wuest (GNS Healthcare)
In the era of precision medicine, analyses of large volumes of data are key to developing targeted and effective therapeutics. This symposium explores how big data and predictive knowledge are used to guide drug development and clinical trials.
Friday, June 19, 2015 | 8:00 AM - 5:30 PM
Speakers: Joel Ackelsberg (NYC Department of Health and Mental Hygiene), Eric Alm (Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology), Martin J. Blaser (New York University Langone Medical Center), Ilana Brito (Massachusetts Institute of Technology), Jane Carlton (New York University Center for Genomics and Systems Biology), Rumi Chunara (New York University Polytechnic School of Engineering), Laurie Garrett (Council on Foreign Relations), Jack Gilbert (Argonne National Laboratory), Jo Handelsman (White House Office of Science and Technology Policy), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), W. Ian Lipkin (Center for Infection and Immunity, Columbia University), Juan Maestre (The University of Texas at Austin), Christopher Mason (Institute for Computational Biomedicine, Weill Cornell Medical College), Paula Olsiewski (Alfred P. Sloan Foundation), Rachel Poretsky (University of Illinois at Chicago), Coby Schal (North Carolina State University Department of Entomology)
Efforts to map all of the genetic information of microbial communities that make up the urban genome—from kiosks and subways, to soil and sewage—seek to improve the health and productivity of the built environments in which we live.
Thursday, June 18, 2015 | 8:00 AM - 5:30 PM
Keynote Speaker: Steve Kay (University of Southern California)
Speakers: Francis J. Doyle III (University of California Santa Barbara), Andrew Ewald, PhD (Johns Hopkins University), Scott E. Fraser (University of Southern California), Peter Kuhn (University of Southern California), Christopher E. Mason (Weill Cornell Medical College), Paul Newton (University of Southern California), Amanda Randles (Harvard University), Chris Sander (Memorial Sloan Kettering Cancer Center)
Quantitative Biology: From Molecules to Man will bring together professionals in science, medicine, and engineering to articulate a vision for the future of improving patient health outcomes.
Thursday, June 11, 2015 | 8:45 AM - 5:15 PM
Keynote Speaker: Jane A. Driver (Brigham and Women's Hospital)
Speakers: Kurt Brunden (University of Pennsylvania), Stuart Calderwood (Harvard Medical School), Gary Landreth (Case Western Reserve University), Tamara Maes, PhD (Oryzon Genomics S.A.), David M. Roy (Memorial Sloan Kettering Cancer Center), Stephen Strittmatter (Yale University School of Medicine), Li Huei Tsai (Massachusetts Institute of Technology), Raymond Scott Turner (Georgetown University), Claes Wahlestedt (University of Miami Miller School of Medicine), Hui Zheng (Baylor College of Medicine)
Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegenerative diseases? This meeting will address these questions to help advance therapeutic development.
Organizers: Nathalie Breysse (Lundbeck Research USA), Elena Dale (Lundbeck Research USA), and Sonya Dougal (The New York Academy of Sciences)
Non-motor symptoms are common but often overlooked in Parkinson's disease. This eBriefing examines new approaches to studying disease mechanisms, which could lead to a better understanding of pathogenesis and to the development of new therapies.
Keynote Speaker: Frank Hu (Harvard T.H. Chan School of Public Health)
This eBriefing explores research on metabolic health from several disciplines and looks at how different types of data combine to explain physiology and disease.
Edited by Claudio Carini
Discusses the development of biomarker-based companion diagnostics to optimize diagnosis and treatment choices.
Keynote Speakers: Miia Kivipelto (Karolinska Institute, Sweden), Irwin H. Rosenberg (Tufts University), and A. David Smith (University of Oxford, UK)
This eBriefing discusses epidemiological evidence for the role of diet in cognitive function and looks at nutritional and lifestyle strategies to delay or prevent dementia.
A recent conference held at the Academy asked a downright outrageous question: Can dementia be prevented by making changes to your diet? In this podcast we look at what the answers might be.
In the second of a two-part series, experts look at the links between health and nutrition. They examine everything from how nutrition impacts hospital stays, to cancer and aging, to developing food science innovations, and improving diet.
In this first of a two-part series, experts from various sectors explore the available options to reduce "hidden hunger"—micronutrient deficiencies in a population.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.